Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy: a systematic review and meta-analysis
Lin AY, Buckley NS, Lu AT, Kouzminova NB, Salpeter SR
 
 
Record Status
This is a systematic review that meets the criteria for inclusion on DARE.
Bibliographic details
Lin AY, Buckley NS, Lu AT, Kouzminova NB, Salpeter SR. Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy: a systematic review and meta-analysis. Clinical Colorectal Cancer 2011; 10(1): 63-69
PubMedID
21609938
DOI
10.3816/CCC.2011.n.009
Original Paper URL
http://www.clinical-colorectal-cancer.com/article/S1533-0028(11)70065-2/abstract
Indexing Status
Subject indexing assigned by NLM
MeSH
Antibodies, Monoclonal /therapeutic use; Colorectal Neoplasms /genetics /mortality /pathology; Confidence Intervals; Disease Progression; Humans; Kaplan-Meier Estimate; Proto-Oncogene Proteins /genetics; Receptor, Epidermal Growth Factor /metabolism; Treatment Failure; United States; ras Proteins /genetics
AccessionNumber
12011004577
Date bibliographic record published
12/10/2011
 
Database of Abstracts of Reviews of Effects (DARE)
Produced by the Centre for Reviews and Dissemination
Copyright © 2025 University of York
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for DARE database users